Markets:

Overview

News

Currencies

International

Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

158.50 -5.95 (-3.62%)

Streaming Delayed Price Updated: 12:13 PM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 Next >

Belite Bio (BLTE) Q4 2025 Earnings Call Transcript ↗

March 03, 2026

Belite Bio (BLTE) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Belite Bio Inc - ADR (NASDAQ:BLTE) Reports Narrower-Than-Expected Q4 Loss, NDA Submission on Track for 2026 ↗

March 02, 2026

Via Chartmill

Why Belite Bio Stock Soared on Monday ↗

December 01, 2025

The company is now tantalizingly close to commercializing its leading drug candidate.

Via The Motley Fool

Top movers in Monday's pre-market session ↗

December 01, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Earnings Outlook For Belite Bio ↗

November 07, 2025

Via Benzinga

Belite Bio's Earnings Outlook ↗

August 08, 2025

Via Benzinga

3 Lesser-Known Healthcare Names With Major Upside in Store ↗

October 02, 2025

These are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity.

Via MarketBeat

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday ↗

May 21, 2025

Via Benzinga

Earnings Outlook For Belite Bio ↗

May 13, 2025

Via Benzinga

Belite Bio Analysts See Potential For Stock Gains With Progress In Key Trials ↗

March 18, 2025

Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results.

Via Benzinga

Earnings Scheduled For March 17, 2025 ↗

March 17, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Insights into Belite Bio's Upcoming Earnings ↗

November 11, 2024

Via Benzinga

BLTE Stock Earnings: Belite Bio Misses EPS for Q2 2024 ↗

August 09, 2024

BLTE stock results show that Belite Bio missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

BLTE Stock Earnings: Belite Bio Misses EPS for Q1 2024 ↗

May 14, 2024

BLTE stock results show that Belite Bio missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Expert Ratings for Belite Bio ↗

December 14, 2023

Via Benzinga

Expert Ratings for Belite Bio ↗

August 10, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023 ↗

July 26, 2023

Via Benzinga

The Latest Analyst Ratings for Belite Bio ↗

July 25, 2023

Via Benzinga

Analyst Expectations for Belite Bio's Future ↗

June 20, 2023

Via Benzinga

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...

Via Benzinga

Why Shares of Belite Bio Soared This Week ↗

June 30, 2023

The clinical-stage biotech company bounced back from a 52-week low late last week.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 ↗

July 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 26, 2023

Via Benzinga

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday ↗

June 26, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 16, 2023

Friday's session saw 32 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.